Skip to content

Advanix™ Biliary M00534370Recalls & reported problems

Boston Scientific Corporation · Biliary Stent with NaviflexTM RX Delivery System · Class 2 · Implant

All models of Advanix Biliary (59)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729787464), received between Sep 18, 2017 and May 14, 2025 — classified as 2 injuries, 1 malfunction.

The most frequently reported specific device problem is “Break” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break2
  • Adverse Event Without Identified Device or Use Problem1
  • Difficult to Remove1
  • Positioning Failure1

Patient problems

  • Foreign Body In Patient1
  • No Clinical Signs, Symptoms or Conditions1
  • Perforation1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 14, 2025Break; Positioning Failure; Break; Positioning Failure

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ADVANIX-NAVIFLEX BILIARY STENT WAS TO BE IMPLANTED IN THE COMMON BILE DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON (B)(6) 2025. DURING THE PROCEDURE, "WHEN THE PROSTHESIS WAS RELEASED, THE CARRIER CATHETER FAILED". THE DEVICE WAS REMOVED, AND THE PROCEDURE WAS COMPLETED. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. NOTE: THIS EVENT HAS BEEN DEEMED AN MDR REPORTABLE EVENT BASED ON THE INVESTIGATION RESULTS WHICH REVEALED THAT THE GUIDE CATHETER WAS DETACHED. PLEASE SEE BLOCK H11 FOR FULL INVESTIGATION DETAILS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22023093 ↗
  • InjuryMar 18, 2024Break; Difficult to Remove; Break; Difficult to Remove

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ADVANIX RX BILIARY PRELOADED DOUBLE PIGTAIL STENT WAS IMPLANTED DURING A PROCEDURE ON AN UNKNOWN DATE. ON (B)(6) 2024, DURING A SCHEDULED ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) WITH A STENT REMOVAL PROCEDURE, THE PHYSICIAN WAS UNABLE TO REMOVE THE EXISTING STENT, AND DURING THE ATTEMPT AT REMOVAL, THE STENT THAT WAS ALREADY IN PLACE BROKE OFF. THE PHYSICIAN WAS ONLY ABLE TO REMOVE A PART OF THE STENT, WHILE A PART OF THE STENT REMAINED IN THE COMMON BILE DUCT. A SECOND ERCP PROCEDURE WAS SCHEDULED TO ATTEMPT THE REMOVAL OF THE REMAINING PART OF THE STENT. THE PATIENT WAS ADMITTED TO THE HOSPITAL FOR OBSERVATION.

    Patient problems: Foreign Body In Patient

    MAUDE report 18925705 ↗
  • InjurySep 18, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ADVANIX¿ BILIARY STENT WAS IMPLANTED IN A PATIENT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED IN THE GALLBLADDER (EXACT IMPLANT DATE NOT REPORTED). ACCORDING TO THE COMPLAINANT, ON (B)(6) 2017, AFTER A FEW DAYS, THE DEVICE ¿AFFECTED THE CONTRA - LATERAL LINING OF THE DUODENUM, CAUSING A PERFORATION, THEREFORE REQUIRING A RE-INTERVENTION IN ORDER TO CLOSE THE LINING¿. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. ATTEMPTS TO ASCERTAIN THE PATIENT¿S CONDITION FOLLOWING THE PROCEDURE HAVE BEEN UNSUCCESSFUL. SHOULD ADDITIONAL RELEVANT DETAILS BECOME AVAILABLE; A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

    Patient problems: Perforation

    MAUDE report 6874056 ↗

Other CATHETER, BILIARY, DIAGNOSTIC devices

All CATHETER, BILIARY, DIAGNOSTIC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page